BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 29859273)

  • 21. miR-216a-targeting theranostic nanoparticles promote proliferation of insulin-secreting cells in type 1 diabetes animal model.
    Wang P; Liu Q; Zhao H; Bishop JO; Zhou G; Olson LK; Moore A
    Sci Rep; 2020 Mar; 10(1):5302. PubMed ID: 32210316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-223-3p regulates cell chemo-sensitivity by targeting FOXO3 in prostatic cancer.
    Feng Q; He P; Wang Y
    Gene; 2018 Jun; 658():152-158. PubMed ID: 29518547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Renal microRNA- and RNA-profiles in progressive chronic kidney disease.
    Rudnicki M; Perco P; D Haene B; Leierer J; Heinzel A; Mühlberger I; Schweibert N; Sunzenauer J; Regele H; Kronbichler A; Mestdagh P; Vandesompele J; Mayer B; Mayer G
    Eur J Clin Invest; 2016 Mar; 46(3):213-26. PubMed ID: 26707063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-96 promotes the proliferation of colorectal cancer cells and targets tumor protein p53 inducible nuclear protein 1, forkhead box protein O1 (FOXO1) and FOXO3a.
    Gao F; Wang W
    Mol Med Rep; 2015 Feb; 11(2):1200-6. PubMed ID: 25369914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential Expression of MicroRNAs in Leprosy Skin Lesions.
    Soares CT; Trombone APF; Fachin LRV; Rosa PS; Ghidella CC; Ramalho RF; Pinilla MG; Carvalho AF; Carrara DN; Soares FA; Belone AFF
    Front Immunol; 2017; 8():1035. PubMed ID: 28970833
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum miRNA expression profiling reveals miR-486-3p may play a significant role in the development of autism by targeting ARID1B.
    Yu D; Jiao X; Cao T; Huang F
    Neuroreport; 2018 Dec; 29(17):1431-1436. PubMed ID: 30260819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exosomal miR-122, miR-128, miR-200, miR-298, and miR-342 as novel diagnostic biomarkers in NAFL/NASH: Impact of LPS/TLR-4/FoxO3 pathway.
    Samy AM; Kandeil MA; Sabry D; Abdel-Ghany AA; Mahmoud MO
    Arch Pharm (Weinheim); 2024 Apr; 357(4):e2300631. PubMed ID: 38574101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Survey of miRNA-mRNA Interactions Reveals That Ccr7 and Cd247 (CD3 zeta) are Posttranscriptionally Controlled in Pancreas Infiltrating T Lymphocytes of Non-Obese Diabetic (NOD) Mice.
    Fornari TA; Donate PB; Assis AF; Macedo C; Sakamoto-Hojo ET; Donadi EA; Passos GA
    PLoS One; 2015; 10(11):e0142688. PubMed ID: 26606254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating miRNAs in diabetic kidney disease: case-control study and in silico analyses.
    Assmann TS; Recamonde-Mendoza M; Costa AR; Puñales M; Tschiedel B; Canani LH; Bauer AC; Crispim D
    Acta Diabetol; 2019 Jan; 56(1):55-65. PubMed ID: 30167868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integrated miRNA and mRNA expression profiling in inflamed colon of patients with ulcerative colitis.
    Van der Goten J; Vanhove W; Lemaire K; Van Lommel L; Machiels K; Wollants WJ; De Preter V; De Hertogh G; Ferrante M; Van Assche G; Rutgeerts P; Schuit F; Vermeire S; Arijs I
    PLoS One; 2014; 9(12):e116117. PubMed ID: 25546151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating microRNAs in young individuals with long-duration type 1 diabetes in comparison with healthy controls.
    Swolin-Eide D; Forsander G; Pundziute Lyckå A; Novak D; Grillari J; Diendorfer AB; Hackl M; Magnusson P
    Sci Rep; 2023 Jul; 13(1):11634. PubMed ID: 37468555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of the MIR155 host gene in physiological and pathological processes.
    Elton TS; Selemon H; Elton SM; Parinandi NL
    Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-487a-3p suppresses the malignant development of pancreatic cancer by targeting SMAD7.
    Zhou J; Qie S; Fang H; Xi J
    Exp Mol Pathol; 2020 Oct; 116():104489. PubMed ID: 32622014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcript Expression Profiles and MicroRNA Regulation Indicate an Upregulation of Processes Linked to Oxidative Stress, DNA Repair, Cell Death, and Inflammation in Type 1 Diabetes Mellitus Patients.
    Takahashi P; Xavier DJ; Lima JEBF; Evangelista AF; Collares CVA; Foss-Freitas MC; Rassi DM; Donadi EA; Passos GA; Sakamoto-Hojo ET
    J Diabetes Res; 2022; 2022():3511329. PubMed ID: 35155683
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs.
    He H; Wang L; Zhou W; Zhang Z; Wang L; Xu S; Wang D; Dong J; Tang C; Tang H; Yi X; Ge J
    PLoS One; 2015; 10(5):e0125672. PubMed ID: 25938468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs in type 1 diabetes: new research progress and potential directions.
    Miao C; Chang J; Zhang G; Fang Y
    Biochem Cell Biol; 2018 Oct; 96(5):498-506. PubMed ID: 29554441
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-149 Aggravates Pyroptosis in Myocardial Ischemia-Reperfusion Damage via Silencing FoxO3.
    Lin J; Lin H; Ma C; Dong F; Hu Y; Li H
    Med Sci Monit; 2019 Nov; 25():8733-8743. PubMed ID: 31741467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritoneal fluid modifies the microRNA expression profile in endometrial and endometriotic cells from women with endometriosis.
    Braza-Boïls A; Salloum-Asfar S; Marí-Alexandre J; Arroyo AB; González-Conejero R; Barceló-Molina M; García-Oms J; Vicente V; Estellés A; Gilabert-Estellés J; Martínez C
    Hum Reprod; 2015 Oct; 30(10):2292-302. PubMed ID: 26307093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNAs in CD4(+) T cell subsets are markers of disease risk and T cell dysfunction in individuals at risk for type 1 diabetes.
    Zhang Y; Feng ZP; Naselli G; Bell F; Wettenhall J; Auyeung P; Ellis JA; Ponsonby AL; Speed TP; Chong MM; Harrison LC
    J Autoimmun; 2016 Apr; 68():52-61. PubMed ID: 26786119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.